Eli Lilly to Spend $260M on Indianapolis Expansion

By AP News

Apr 03, 2013

Bloomberg Businessweek

Drugmaker Eli Lilly and Co. is planning to spend about $260 million to expand insulin production and make other capital improvements to sites in its home city of Indianapolis.The company plans to spend about $180 million on new construction, the addition of another insulin cartridge-filling line, and the installation of new equipment. Read the full story
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments